Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Anixa Biosciences Inc | form10k.htm |
| EX-99.1 - EXHIBIT 99.3 - Anixa Biosciences Inc | exhibit99_3.htm |
| EX-99.2 - EXHIBIT 99.2 - Anixa Biosciences Inc | exhibit99_2.htm |
| EX-99.1 - EXHIBIT 99.1 - Anixa Biosciences Inc | exhibit99_1.htm |
| EX-32.1 - EXHIBIT 32.1 - Anixa Biosciences Inc | exhibit32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Anixa Biosciences Inc | exhibit31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - Anixa Biosciences Inc | exhibit31_1.htm |
| EX-23.1 - EXHIBIT 23.1 - Anixa Biosciences Inc | exhibit23_1.htm |
| EX-21 - EXHIBIT 21 - Anixa Biosciences Inc | exhibit21.htm |
| EX-10.21 - EXHIBIT 10.21 - Anixa Biosciences Inc | exhibit10_21.htm |
| EX-10.20 - EXHIBIT 10.20 - Anixa Biosciences Inc | exhibit10_20.htm |
| EX-10.19 - EXHIBIT 10.19 - Anixa Biosciences Inc | exhibit10_19.htm |
| EX-4.2 - EXHIBIT 4.2 - Anixa Biosciences Inc | exhibit4_2.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Michael J. Catelani, Chief Financial Officer of ITUS Corporation, hereby certifies that:
1.
The Company's Form 10-K Annual Report for the fiscal year ended October 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: December 7, 2015 | /s/ Michael J. Catelani |
|
| Michael J. Catelani |
|
| Chief Financial Officer |